CHRNA5 Antikörper (Middle Region)

Produktnummer ABIN927521

Der Kaninchen Polyklonal anti-CHRNA5 Antikörper wird verwendet zum Nachweis von CHRNA5 in Proben von Human. Er wurde validiert für WB.

Kurzübersicht für CHRNA5 Antikörper (Middle Region) (ABIN927521)

Target: CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CHRNA5 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-CHRNA5 Antikörper

Bindungsspezifität: Middle Region

Aufreinigung: Purified

Immunogen: CHRNA5 antibody was raised in rabbit using the middle region of CHRNA5 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

CHRNA5 Blocking Peptide, (ABIN5612865), is also available for use as a blocking control in assays to test for specificity of this CHRNA5 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu CHRNA5

Target: CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))

Andere Bezeichnung: CHRNA5

Hintergrund: Nicotinic acetylcholine receptors (nAChRs), such as CHRNA5, are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits. Synonyms: Polyclonal CHRNA5 antibody, Anti-CHRNA5 antibody, cholinergic receptor, nicotinic, alpha 5 antibody, LNCR2 antibody.